This site is intended for Healthcare Professionals only.

Drop in COVID alertness could create deadly new variant, says Tedros Adhanom Ghebreyesus

Date:

Share post:

Lapses in strategies to tackle COVID-19 this year continue to create the perfect conditions for a deadly new variant to emerge, as parts of China witness a rise in infections, the head of the World Health Organization said on Friday (December 2).

The comments by WHO Director-General Tedros Adhanom Ghebreyesus mark a change in tone just months after he said that the world has never been in a better position to end the pandemic.

“We are much closer to being able to say that the emergency phase of the pandemic is over, but we’re not there yet,” Tedros said on Friday.

The global health agency estimates that about 90% of the world’s population now has some level of immunity to SARS-COV-2 either due to prior infection or vaccination.

“Gaps in testing … and vaccination are continuing to create the perfect conditions for a new variant of concern to emerge that could cause significant mortality,” Tedros said.

COVID-19 infections are at record highs in China and have started to rise in parts of Britain after months of decline.

Further easing of COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest.

“While COVID-19 and flu can be mild infections for many, we must not forget that they can cause severe illness or even death for those most vulnerable in our communities”, Mary Ramsay, director of public health programmes at the UK Health Security Agency, said.

The WHO urged governments globally to focus on reaching those at risk, such as people over the age of 60 and those with underlying conditions, for vaccination.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Paul Adams appointed as new CEO of LloydsPharmacy Clinical Homecare

Adams is committed to creating healthcare systems that are both efficient and empathetic LloydsPharmacy Clinical Homecare, a leading...

RPS welcomes NHSE’s report on the involvement of pharmacy professionals in research

Protected time and support identified as the most significant enablers for fostering clinical academic pharmacy careers The NHS...

MHRA approves first drug via the new IRP in 30 days

XGEVA is the first product to be authorised by the regulator through the new International Recognition Procedure (IRP)....

From Skincare to Sleep Aid: Surprising Uses of CBD

Are you curious about the latest trend in wellness and self-care? CBD, or cannabidiol, has been making ripples...